Disopyramide and Histrelin: Interaction Details

Brand names
Disopyramide
NorpaceNorpace CR
Histrelin
Supprelin
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Disopyramide

Brand names
  • Norpace
  • Norpace CR

Histrelin

Brand name
  • Supprelin

We don't have a drug information page for Histrelin yet. Have a question about Histrelin? Ask a pharmacist, free →

What Happens When You Take Disopyramide With Histrelin

What can happen when they are taken together (rated Major)

Increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

When histrelin is given together with medications that lengthen the , their effects on the QT interval are . GnRH and can lengthen the QT interval as a consequence of the androgen deprivation they produce.

In patients who have congenital long QT syndrome, congestive heart failure, or recurrent electrolyte disturbances, as well as in those receiving drugs known to lengthen the QT interval, weigh whether the benefits of androgen deprivation therapy such as histrelin justify its potential risks.3 Where possible, histrelin should not be combined with QT prolonging agents. When cannot be avoided, refrain from using drugs that produce electrolyte disturbances (ie, or ),1 correct any electrolyte abnormalities, and consider periodically monitoring ECGs and electrolytes.3

The Disopyramide and Histrelin Interaction, Explained

Disopyramide (Norpace) is a heart rhythm medicine, and it can affect the heart's electrical timing, called the . Histrelin (Supprelin) lowers sex hormones like testosterone, and lower hormone levels can also stretch out the QT interval. Taking both together could add up and raise the chance of an irregular heartbeat.

The good news is that this concern is mostly theoretical, based on how the drugs work. Your care team may monitor you more closely, such as checking your heart rhythm and blood minerals. Tell them right away if you feel dizzy, faint, or notice a racing or pounding heartbeat.

Mechanism: . Disopyramide is a class IA antiarrhythmic that blocks sodium and potassium (IKr) channels, which causes QT prolongation and carries a risk. Histrelin is a GnRH , and androgen deprivation may prolong the . No interaction is expected.

Severity: major. Onset: unspecified. Evidence: theoretical.

  • Avoid the combination when possible, and weigh the benefit of androgen deprivation therapy, especially with congenital long QT, CHF, or recurrent electrolyte disturbances.
  • If is required, correct and and avoid drugs that cause them.
  • Consider periodic and electrolyte monitoring.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Disopyramide and Histrelin Interact

The likely mechanism

In short: Disopyramide and histrelin both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Disopyramide and Histrelin Interaction

Care teams usually try to avoid using these two medicines together when possible. If both are needed, your team can manage it by:

  • Weighing the benefits of histrelin against heart risks, especially if you have heart failure or a long QT condition
  • Checking and correcting potassium and magnesium levels
  • Avoiding other medicines that lower these minerals
  • Possibly doing periodic ECGs (heart tracings) and blood tests

What you can do: Keep taking both medicines as prescribed. Tell your pharmacist or prescriber about all your medicines, and report fainting, dizziness, or a pounding heartbeat right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Disopyramide or Histrelin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes

    A study of male patients on androgen deprivation therapy (ADT) used individual case safety reports from the international pharmacovigilance database VigiBase and identified 184 cases of acquired long-QT syndrome (aLQTS) and/or (TdP; 11% fatal cases), along with 99 cases of sudden death associated with ADT. The majority of ADT-associated aLQTS/TdP cases (62%) and sudden death cases (88%) occurred without exposure to other drugs known to increase TdP risk.

    However, exposure to 1 drug and 2 or more drugs with conditional, possible, or known TdP risk was reported in some aLQTS/TdP events (23% or 43%) and sudden death events (18% and 22%). The drugs classified as ADTs were abiraterone, gonadotropin-releasing hormone and , nonsteroidal androgen receptor indicated for prostate cancer, and 5-alpha-reductase inhibitors indicated for androgenic alopecia and prostatism.

    Among the 10 ADTs assessed, 7 showed a disproportional association (reporting odds ratio, 1.4 to 4.7) with aLQTS, TdP, or sudden death, namely leuprorelin, goserelin, triptorelin, degarelix, bicalutamide, finasteride, and dutasteride. The median patient age was about 76 years.

    The median time to onset was 170 days (range, 7 to 4884 days) for aLQTS/TdP events and 92 days (range, 0.25 to 4984 days) for sudden death events. ADT was given mainly for prostate cancer, with some patients receiving it for prostatism and androgenic alopecia. Most patients received ADT monotherapy (83%), and 17% received ADT combination therapy.2

Disopyramide and Histrelin: Common Questions

How serious is the Disopyramide and Histrelin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Disopyramide and Histrelin interaction managed?

Care teams usually try to avoid using these two medicines together when possible. If both are needed, your team can manage it by: Weighing the benefits of histrelin against heart risks, especially if you have heart failure or a long QT condition Checking and correcting potassium and magnesium levels Avoiding other medicines that lower these minerals Possibly doing periodic ECGs (heart tracings) an… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Disopyramide and Histrelin Interaction

Ask in your own words about taking Disopyramide and Histrelin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Lyon AR, Lopez-Fernandez T, Couch LS, et al: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022; 43(41):4229-4361.
  2. Salem JE, Yang T, Moslehi JJ, et al: Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes. Circulation 2019; 140(13):1070-1080. PubMed
  3. Product Information: VANTAS® subcutaneous implant, histrelin acetate subcutaneous implant. Endo Pharmaceuticals Solutions Inc, Malvern, PA, 2026. DailyMed
Was this write-up helpful?

Other Serious Interactions of Disopyramide and Histrelin

Also serious with Disopyramide

Also serious with Histrelin

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.